ARTICLE | Company News
Somatix deal
September 20, 1993 7:00 AM UTC
SOMA acquired an exclusive license to a family of tumor markers from the Ludwig Institute for Cancer Research. The institute will receive payments to support its research into the proteins, called MAGE-1 antigens. MAGE proteins are some of the few markers expressed by a wide variety of cancer cells that can be targeted by the human immune system, the company said. ...